Improving speech production in children with childhood apraxia of speech
A randomized control trial of motor-based intervention for childhood apraxia of speech
This study is looking at a new way to help kids with childhood apraxia of speech (CAS) improve their ability to speak clearly, using a method called Dynamic Temporal and Tactile Cuing (DTTC), and it aims to see how well this treatment works for them over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10815805 on NIH RePORTER |
What this research studies
This research investigates a treatment approach called Dynamic Temporal and Tactile Cuing (DTTC) for children diagnosed with childhood apraxia of speech (CAS), a disorder that affects their ability to plan and execute speech movements. The study will involve a randomized control trial with 72 young participants, assessing how effective DTTC is in improving their speech production skills. Researchers will evaluate not only the immediate effects on specific words but also how these improvements generalize to other words and persist over time. The goal is to establish evidence-based guidelines for treating CAS, ultimately enhancing communication abilities in affected children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who have been diagnosed with childhood apraxia of speech.
Not a fit: Patients who do not have childhood apraxia of speech or are outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve speech production and communication skills in children with childhood apraxia of speech.
How similar studies have performed: Previous research has shown promising results with similar multimodal approaches to speech therapy, indicating potential for success in this trial.
Where this research is happening
New York, United States
- New York University — New York, United States (Active)
Researchers
- Principal investigator: Grigos, Maria Irene — New York University
- Study coordinator: Grigos, Maria Irene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.